Literature DB >> 31038748

High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.

Francisco Maduell1, Lida Rodas1, José Jesús Broseta1, Miguel Gómez1, Marc Xipell Font1, Alicia Molina1, Enrique Montagud-Marrahi1, Elena Guillén1, Marta Arias-Guillén1, Nestor Fontseré1, Manel Vera Rivera1, Nayra Rico2.   

Abstract

Most high-flux dialyzers can be used in both hemodialysis (HD) and online hemodiafiltration (OL-HDF). However, some of these dialyzers have higher permeability and should not be prescribed for OL-HDF to avoid high albumin losses. The aim of this study was to compare the safety and efficacy of a currently used dialyzer in HD and OL-HDF with those of several other high permeability dialyzers which should only be used in HD. A prospective, single-center study was carried out in 21 patients. Each patient underwent 5 dialysis sessions with routine dialysis parameters: 2 sessions with Helixone (HD and postdilution OL-HDF) and 1 session each with steam sterilized polyphenylene, polymethylmethacrylate (PMMA), and medium cut-off (MCO) dialyzers in HD treatment. The removal ratios (RR) of urea, creatinine, ß2 -microglobulin, myoglobin, prolactin, α1 -microglobulin, α1 -acid glycoprotein, and albumin were compared intraindividually. A proportional part of the dialysate was collected to quantify the loss of various solutes, including albumin. Urea and creatinine RRs with the Helixone-HDF and MCO dialyzers were higher than with the other 3 dialyzers in HD. The β2 -microglobulin, myoglobin and prolactin RRs with Helixone-HDF treatment were significantly higher than those obtained with all 4 dialyzers in HD treatment. The β2 -microglobulin value obtained with the MCO dialyzer was also higher than that obtained with the other 3 dialyzers in HD treatment. The myoglobin RR with MCO was higher than those obtained with Helixone and PMMA in HD treatment. The prolactin RR with Helixone-HD was significantly lower than those obtained in the other 4 study sessions. The α1 -microglobulin and α1 - acid glycoprotein RRs with Helixone-HDF were significantly higher than those obtained with Helixone and PMMA in HD treatment. The albumin loss varied from 0.54 g with Helixone-HD to 3.3 g with polyphenylene. The global removal score values ((UreaRR + β2 -microglobulinRR + myoglobinRR + prolactinRR + α1 -microglobulinRR + α1 -acid glycoproteinRR - albuminRR )/6) were 43.7% with Helixone-HD, 47.7% with PMMA, 54% with polyphenylene, 54.8% with MCO and 59.6% with Helixone-HDF, with significant differences. In conclusion, this study confirms the superiority of OL-HDF over HD with the high-flux dialyzers that allow both treatments. Although new dialyzers with high permeability can only be used in HD, they are in an intermediate position and some are very close to OL-HDF.
© 2019 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  dialyzer; hemodiafiltration; hemodialysis; medium cut-off membranes; polymethylmethacrylate; polyphenylene

Mesh:

Substances:

Year:  2019        PMID: 31038748     DOI: 10.1111/aor.13480

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  6 in total

1.  Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.

Authors:  Masanori Abe; Ikuto Masakane; Atsushi Wada; Shigeru Nakai; Kosaku Nitta; Hidetomo Nakamoto
Journal:  Clin Kidney J       Date:  2021-09-28

2.  Effects of Medium Cut-Off Versus High-Flux Hemodialysis Membranes on Biomarkers: A Systematic Review and Meta-Analysis.

Authors:  Maryam Kandi; Romina Brignardello-Petersen; Rachel Couban; Celina Wu; Gihad Nesrallah
Journal:  Can J Kidney Health Dis       Date:  2022-01-18

3.  Efficacy and safety of expanded hemodialysis in hemodialysis patients: a meta-analysis and systematic review.

Authors:  Yuchao Zhao; Liangying Gan; Qingyu Niu; Mengfan Ni; Li Zuo
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

4.  A comparative analysis of high-flux and low-flux dialysis in cervical cancer patients with obstructive renal failure showing no significantly improved renal function after catheterisation.

Authors:  Chen-Li Zhang; De-Qiong Xie; Li-Na Ao; Lei Zhu
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

5.  Randomised trial on clinical performances and biocompatibility of four high-flux hemodialyzers in two mode treatments: hemodialysis vs post dilution hemodiafiltration.

Authors:  Marion Morena; Caroline Creput; Mouloud Bouzernidj; Annie Rodriguez; Lotfi Chalabi; Bruno Seigneuric; Céline Lauret; Anne-Sophie Bargnoux; Anne-Marie Dupuy; Jean-Paul Cristol
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

6.  Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report.

Authors:  Charles Cuvelier; Michel Tintillier; Gabriela Migali; Charlotte Van Ende; Jean-Michel Pochet
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.